Skip to content
zameds

Coagulation factor viii, simoctocog alfa

Sold as Nuwiq

Every registration of this product has been cancelled.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
1
Registrations
4

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Octapharma South Africa (Pty) LtdCancelledNuwiq000 IU 1, 000 IU 2, 250 IU, 500 IU530726, 530727, 530728, 530729Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Nuwiq 250 IU

EACH VIAL CONTAINS SIMOCTOCOG ALFA, COAGULATION FACTOR VIII 250,0 IU

250 IU53072653/30.3/0726CancelledNot determinedNone
Nuwiq 500 IU

EACH VIAL CONTAINS SIMOCTOCOG ALFA, COAGULATION FACTOR VIII 500,0 IU

500 IU53072753/30.3/0727CancelledNot determinedNone
Nuwiq 1 000 IU

EACH VIAL CONTAINS SIMOCTOCOG ALFA, COAGULATION FACTOR VIII 1 000,0 IU

000 IU 153072853/30.3/0728CancelledNot determinedNone
Nuwiq 2 000 IU

EACH VIAL CONTAINS SIMOCTOCOG ALFA, COAGULATION FACTOR VIII 2 000,0 IU

000 IU 253072953/30.3/0729CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles